Tower Research Capital LLC (Trc) Bellerophon Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.76 $5 - $11	-15 Reduced 0.21%	7,135 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.68 - $12.39 $4,531 - $82,566	6,664 Added 1371.19%	7,150 $4,000
Q1 2023 May 09, 2023	SELL	$0.9 - $7.89 $4,847 - $42,495	-5,386 Reduced 91.72%	486 $4,000
Q4 2022 Feb 10, 2023	SELL	$0.67 - $1.2 $1,131 - $2,026	-1,689 Reduced 22.34%	5,872 $5,000
Q3 2022 Nov 10, 2022	SELL	$0.96 - $1.69 $2,941 - $5,178	-3,064 Reduced 28.84%	7,561 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $2.36 $7,691 - $21,355	9,049 Added 574.18%	10,625 $13,000
Q1 2022 May 12, 2022	BUY	$1.82 - $3.24 $1,597 - $2,844	878 Added 125.79%	1,576 $4,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $4.05 $1,647 - $2,826	698 New	698 $2,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $5.65 $8,161 - $12,040	-2,131 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.07 - $8.27 $3,493 - $5,698	689 Added 47.78%	2,131 $11,000
Q4 2020 Feb 16, 2021	SELL	$6.12 - $10.37 $12,913 - $21,880	-2,110 Reduced 59.4%	1,442 $10,000
Q3 2020 Nov 16, 2020	BUY	$9.27 - $13.79 $31,341 - $46,623	3,381 Added 1977.19%	3,552 $36,000
Q2 2020 Aug 13, 2020	BUY	$9.43 - $20.28 $1,612 - $3,467	171 New	171 $2,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $95.5K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.